Evan G. Dick - Oct 19, 2021 Form 3/A - Amendment Insider Report for Context Therapeutics Inc. (CNTX)

Role: SVP of R&D
Signature: /s/ Alex Levit, Attorney-in-Fact
Stock symbol: CNTX
Transactions as of: Oct 19, 2021
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 12/17/2021, 03:10 PM
Date Of Original Report: Oct 19, 2021
Next filing: Oct 25, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CNTX	Common Stock						56.4K	Oct 19, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 33,397 restricted stock units which fully vest on January 31, 2023.

Remarks:

The numbers in Table 1 and the footnote thereto (including the date in the footnote) in this Form are to correct the respective numbers filed in the original Form 3 on October 19, 2021.